FDA To Phase Out Animal Testing In The Development Of Monoclonal Antibodies, Other Drugs

RTTNews | 587 hari yang lalu
FDA To Phase Out Animal Testing In The Development Of Monoclonal Antibodies, Other Drugs

(RTTNews) - The U.S. Food and Drug Administration has announced a plan to replace animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.

The plan is in line with the agency's efforts to modernize regulatory science as technology advances, and follows the demand by Congress and the scientific community over the years for more human-relevant testing methods.

The health regulator noted that the proposed elimination of animal testing is designed to improve drug safety and accelerate the evaluation process, while reducing animal experimentation, lowering research and development or R&D costs, and eventually drug prices.

According to the FDA Commissioner Martin Makary, the proposal means a more efficient pipeline for novel treatments for patients, and its an added margin of safety, since human-based test systems may better predict real-world outcomes. In addition, for animal welfare, it represents a major step towards ending the use of laboratory animals in drug testing with thousands of animals, including dogs and primates, eventually be spared each year.

Implementation of the regimen will begin immediately for investigational new drug or IND applications, where inclusion of New Approach Methodologies or NAMs data is encouraged.

Over the coming year, the FDA aims to launch a pilot program allowing select monoclonal antibody developers to use a primarily non-animal-based testing strategy, which will be under close FDA consultation.

To make determinations of efficacy, the FDA will also begin using pre-existing, real-world safety data from other countries, with comparable regulatory standards, where the drug has already been studied in humans.

The agency is also releasing a roadmap, which will be discussed by the FDA and its federal partners through a public workshop to be hosted later this year.

The FDA expects that animal testing requirement will be reduced, refined, or potentially replaced using a range of approaches. These would include AI-based computational models of toxicity and cell lines and organoid toxicity testing in a laboratory setting.

Replacing animal testing in monoclonal antibody safety evaluation encourages developers to leverage computer modeling and artificial intelligence to predict a drug's behavior, which will drastically reduce the need for animal trials.

Further, the agency will promote the use of lab-grown human "organoids" and organ-on-a-chip systems that mimic human organs, such as liver, heart, and immune organs, to test drug safety. These experiments can reveal toxic effects and provide a more direct window into human responses. Such toxic effects, if any, could easily go undetected in animals.

The guidelines of the agency will be updated to allow consideration of data from these new methods. With that, companies that submit strong safety data from non-animal tests may receive streamlined review, as the need for certain animal studies is eliminated.

In addition, the FDA expects that the use of these modern techniques would help speed up the drug development process, enabling monoclonal antibody therapies to reach patients more quickly without compromising safety.

For More Such Health News, visit rttnews.com

baca selengkapnya
Thai Stock Market May See Renewed Selling Pressure On Friday

Thai Stock Market May See Renewed Selling Pressure On Friday

The Thai stock market on Thursday ended the three-day slide in which it had given up almost 35 points or 2.2 percent. The Stock Exchange of Thailand now sits just above the 1,470-point plateau although it may turn lower again on Friday.
RTTNews | 2 jam 28 menit yang lalu
Japanese Market Sharply Lower; Plunging 3.7%

Japanese Market Sharply Lower; Plunging 3.7%

The Japanese market is trading sharply lower on Friday, reversing the gains in the previous two sessions, following the broadly negative cues from Wall Street overnight. The Nikkei 225 is tumbling 3.7 percent to below the 57,250 level, with weakness across most sectors led by index heavyweights and technology stocks.
RTTNews | 2 jam 53 menit yang lalu
Indonesia Stock Market Tipped To Open In The Red

Indonesia Stock Market Tipped To Open In The Red

The Indonesia stock market has finished lower in four straight sessions, retreating more than 125 points or 2.2 percent along the way. The Jakarta Composite Index now sits just beneath the 5,200-point plateau and it's looking at another soft start again on Friday.
RTTNews | 2 jam 58 menit yang lalu
Lower Open Predicted For Hong Kong Stock Market

Lower Open Predicted For Hong Kong Stock Market

The Hong Kong stock market has finished lower in three straight sessions, sinking more than 900 points or 4 percent along the way. The Hang Seng now sits just beneath the 22,850-point plateau and it figures to see continued consolidation again on Friday.
RTTNews | 3 jam 13 menit yang lalu
Australian Market Significantly Lower

Australian Market Significantly Lower

The Australian stock market is trading significantly lower on Friday, extending the losses in the previous six sessions, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling to near the 8,650 level, with weakness across most sectors led by gold miners and technology stocks.
RTTNews | 3 jam 18 menit yang lalu
China Stock Market Tipped To Open Under Water On Friday

China Stock Market Tipped To Open Under Water On Friday

The China stock market turned lower again on Thursday, one day after ending the four-day losing streak in which it had slumped almost 100 points or 2.7 percent. The Shanghai Composite Index now sits just beneath the 3,580-point plateau and the losses may accelerate on Friday.
RTTNews | 3 jam 27 menit yang lalu
Taiwan Stock Market May Take Further Damage On Friday

Taiwan Stock Market May Take Further Damage On Friday

The Taiwan stock market turned lower again on Thursday, one day after ending the two-day losing streak in which it had tumbled almost 3,600 points or 8.6 percent. The Taiwan Stock Exchange now sits just beneath the 38,430-point plateau and it may extend its losses on Friday.
RTTNews | 3 jam 57 menit yang lalu